VYNE Therapeutics Inc. (VYNE)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
2.79
0.04 (1.45%)
At close: Jan 15, 2025, 3:43 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Net Income | -28.45M | -23.21M | -73.33M | -255.57M | -73.70M | -51.45M | -29.08M | -14.07M | -4.61M |
Depreciation & Amortization | n/a | 72.00K | 109.00K | 341.00K | 700.00K | 22.00K | 8.00K | 4.00K | n/a |
Stock-Based Compensation | 3.31M | 4.30M | 8.08M | 18.10M | 6.70M | 3.64M | 1.45M | 573.00K | 65.00K |
Other Working Capital | 214.00K | -349.00K | -371.00K | -4.17M | 1.41M | -8.55M | -1.74M | 10.18M | 360.00K |
Other Non-Cash Items | -254.00K | -12.64M | 2.47M | 84.07M | -691.00K | -774.00K | 31.00K | 705.00K | 65.00K |
Deferred Income Tax | n/a | n/a | 1.52M | 56.30M | n/a | n/a | 60.00K | -573.00K | n/a |
Change in Working Capital | 60.00K | 2.28M | 4.78M | -40.33M | 1.89M | -4.17M | -722.00K | 11.07M | 360.00K |
Operating Cash Flow | -25.34M | -29.20M | -56.37M | -137.08M | -65.10M | -52.73M | -28.25M | -2.29M | -4.18M |
Capital Expenditures | n/a | n/a | n/a | -113.00K | -11.00K | -140.00K | -27.00K | -31.00K | n/a |
Acquisitions | 5.00M | 15.67M | n/a | 38.64M | 40.00K | n/a | -25.00K | n/a | n/a |
Purchase of Investments | -62.35M | n/a | n/a | -38.64M | -83.40M | -126.70M | -64.15M | -55.31M | n/a |
Sales Maturities Of Investments | n/a | n/a | 1.03M | 50.58M | 124.78M | 92.96M | 49.11M | 17.85M | n/a |
Other Investing Acitivies | n/a | 15.67M | n/a | 38.64M | -40.00K | n/a | 25.00K | n/a | n/a |
Investing Cash Flow | -57.35M | 15.67M | 1.03M | 89.11M | 41.37M | -33.88M | -15.06M | -37.49M | n/a |
Debt Repayment | n/a | n/a | -36.43M | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -360.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -427.00K | 183.00K | 228.00K | 169.00K | 465.00K | 496.00K | 49.49M | n/a | 47.72M |
Financial Cash Flow | 82.39M | 1.65M | 39.78M | 61.81M | 4.99M | 125.91M | 49.49M | n/a | 47.72M |
Net Cash Flow | -301.00K | -11.88M | -15.56M | 13.83M | -18.73M | 39.30M | 6.18M | -39.78M | 43.53M |
Free Cash Flow | -25.34M | -29.20M | -56.37M | -137.19M | -65.11M | -52.87M | -28.27M | -2.32M | -4.18M |